Press Releases

VIVO Cannabis™ Subsidiary, Beacon Medical Germany GmbH, Receives First Permit to Import Medical Cannabis from Canada into Germany

TORONTO, Ontario, July 29, 2021 – VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”) and ABcann Medicinals Inc. (“ABcann”), today announced that its EU-GMP/GDP licensed subsidiary Beacon Medical […]

Read More

VIVO Cannabis™ Launches Canna Farms™ Brick Hash and Large Format Pink Kush Flower to Online Medical Marketplace

TORONTO, Ontario, July 22, 2021 – VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”) and ABcann Medicinals Inc., today announced the launch of Canna Farms™ Brick Hash, a […]

Read More

VIVO CANNABIS™ ANNOUNCES RESULTS OF 2021 AGM AND ELECTION OF NEW DIRECTORS

TORONTO, Ontario, July 5, 2021 – VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”), a leading provider of premium cannabis products and services, is pleased to announce the results of its annual general and special meeting of shareholders held today (the “Meeting”). As announced this morning, certain directors of the Company withdrew […]

Read More

VIVO Announces Board Changes

Annual and Special Meeting Proceeding as Scheduled Toronto, Ontario–(Newsfile Corp. – July 5, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“), a leading provider of premium cannabis products and services, today announced that John Easson, Christie Henderson, Daryl Kramp and Rick Fitzgerald (whose temporary appointment as Interim Chief Executive Officer […]

Read More

VIVO Cannabis™ Launches Premium Topical CBD Cream infused with Terpenes: unique formulation designed for medical users

TORONTO, Ontario, June 3, 2021 – VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”) and ABcann Medicinals Inc. (“ABcann”), today announced the launch of Beacon Medical™ Extra Strength […]

Read More

May 17, 2021

VIVO Cannabis™ Announces First Quarter 2021 Results

Net revenue of $5.5 million – a decrease of 11% over Q4 2020 Vanluven facility received EU-GMP certification allowing VIVO to export cannabis products for sale in Europe and Beacon Medical…

Read More

April 15, 2021

VIVO Cannabis™ Announces Appointment of Ray Laflamme to the Board

VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce the appointment of Ray Laflamme to the board of directors of the Company (the “Board”), effective as…

Read More

March 31, 2021

VIVO Cannabis™ Announces Fourth Quarter 2020 Results

Net revenue for Q4 2020 was $6.2 million; Net revenue for 2020 was $32.8 million, an increase of over 32% compared with the same period last year Recorded first significant revenues from VIVO’s…

Read More

March 17, 2021

VIVO Cannabis Announces Date for Fourth Quarter 2020 Results

VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company”) today announced that the Company will release its fourth quarter 2020 results on Tuesday, March 30, 2021, after the close of…

Read More

March 11, 2021

VIVO Announces EU-GMP Certification

VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company”) today announced that its Vanluven facility in Napanee Ontario has received EU-GMP (European Union Good Manufacturing…

Read More

VIVO is a family of premium brands and businesses, building a world-class cannabis company through the acquisition and development of specialty brands.